Cleared Traditional

K841673 - HAEMOPHILUS ISOLATION AGAR 2827

K841673 is the FDA 510(k) clearance for HAEMOPHILUS ISOLATION AGAR 2827 by Gibco Laboratories Life Technologies, Inc.. It is a Class 1 Microbiology device (product code JSJ) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1984
Decision
28d
Days
Class 1
Risk

K841673 is an FDA 510(k) clearance for the HAEMOPHILUS ISOLATION AGAR 2827. Classified as Culture Media, Selective And Non-differential (product code JSJ), Class I - General Controls.

Submitted by Gibco Laboratories Life Technologies, Inc. (Mchenry, US). The FDA issued a Cleared decision on May 21, 1984 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2360 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gibco Laboratories Life Technologies, Inc. devices

Submission Details

510(k) Number K841673 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 1984
Decision Date May 21, 1984
Days to Decision 28 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 102d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JSJ Culture Media, Selective And Non-differential
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2360
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JSJ Culture Media, Selective And Non-differential

All 239
Devices cleared under the same product code (JSJ) and FDA review panel - the closest regulatory comparables to K841673.
SFP AGAR PLATES
K834424 · Otisville Biotech, Inc. · Oct 1984
BIOTIS MYCOBIOTIC AGAR
K843765 · Otisville Biotech, Inc. · Oct 1984
BIOTIS MYCOLOGICAL MEDIA & SLANT
K843766 · Otisville Biotech, Inc. · Oct 1984
CAMPYLOBACTER AGAR BASE
K840332 · Oxoid U.S.A., Inc. · May 1984
KF STREPTOCOCCUS AGAR
K841658 · Oxoid U.S.A., Inc. · May 1984
MYCOSEL AGAR W/CHLORAMPHENICOL &
K841135 · Anaerobe Systems · Mar 1984